Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas R Adkins

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Current Opinion in Hematology|October 4, 2008
Total body irradiation before an allogeneic stem cell transplantation: is there a magic dose?Douglas R Adkins, John F DiPersio
Cancer Treatment Reviews|June 26, 2022
Clinical trial data of Anti-PD-1/PD-L1 therapy for recurrent or metastatic nasopharyngeal Carcinoma: A reviewDouglas R Adkins, Robert I Haddad
Oral Oncology|September 24, 2017
Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinomaGlenn J Hanna, Douglas R Adkins, Paul Zolkind, et al.
Oral Oncology|August 12, 2017
Trials in head and neck oncology: Evolution of perioperative adjuvant therapyJoseph Zenga, Patrik Pipkorn, Douglas R Adkins, et al.
The Laryngoscope|December 20, 2007
Temporal relationship between antitumor necrosis factor-alpha antibody therapy and recrudescence of head and neck squamous cell carcinomaSamuel H Engel, Timothy E Hullar, Douglas R Adkins, et al.
Cancer Medicine|February 28, 2014
Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapyAaron D Schenone, Jingqin Luo, Luke Montgomery, et al.
The Laryngoscope|July 3, 2009
Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factorsJason T Rich, Simon Milov, James S Lewis, et al.
The Journal of Laboratory and Clinical Medicine|January 9, 2003
Recent advances in allogeneic hematopoietic stem-cell transplantationSteven M Devine, Douglas R Adkins, Hanna Khoury, et al.
Nature Reviews. Clinical Oncology|December 10, 2024
T cell dynamics with neoadjuvant immunotherapy in head and neck cancerMaryann Zhao, Jonathan D Schoenfeld, Ann Marie Egloff, et al.
Head & Neck|September 28, 2010
Squamous cell cancer of the head and neck with distant metastasis at presentationDavid I Kuperman, Vorachart Auethavekiat, Douglas R Adkins, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Current Opinion in Hematology|October 4, 2008
Total body irradiation before an allogeneic stem cell transplantation: is there a magic dose?Douglas R Adkins, John F DiPersio
Cancer Treatment Reviews|June 26, 2022
Clinical trial data of Anti-PD-1/PD-L1 therapy for recurrent or metastatic nasopharyngeal Carcinoma: A reviewDouglas R Adkins, Robert I Haddad
Oral Oncology|September 24, 2017
Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinomaGlenn J Hanna, Douglas R Adkins, Paul Zolkind, et al.
Oral Oncology|August 12, 2017
Trials in head and neck oncology: Evolution of perioperative adjuvant therapyJoseph Zenga, Patrik Pipkorn, Douglas R Adkins, et al.
The Laryngoscope|December 20, 2007
Temporal relationship between antitumor necrosis factor-alpha antibody therapy and recrudescence of head and neck squamous cell carcinomaSamuel H Engel, Timothy E Hullar, Douglas R Adkins, et al.
Cancer Medicine|February 28, 2014
Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapyAaron D Schenone, Jingqin Luo, Luke Montgomery, et al.
The Laryngoscope|July 3, 2009
Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factorsJason T Rich, Simon Milov, James S Lewis, et al.
The Journal of Laboratory and Clinical Medicine|January 9, 2003
Recent advances in allogeneic hematopoietic stem-cell transplantationSteven M Devine, Douglas R Adkins, Hanna Khoury, et al.
Nature Reviews. Clinical Oncology|December 10, 2024
T cell dynamics with neoadjuvant immunotherapy in head and neck cancerMaryann Zhao, Jonathan D Schoenfeld, Ann Marie Egloff, et al.
Head & Neck|September 28, 2010
Squamous cell cancer of the head and neck with distant metastasis at presentationDavid I Kuperman, Vorachart Auethavekiat, Douglas R Adkins, et al.
Pageof 7